Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Document › Details

BioLamina AB. (8/16/23). "Press Release: BioLamina Announces Appointment of New Management Team Members".

Organisations Organisation BioLamina AB
  Group BioLamina (Group)
  Organisation 2 Mercodia AB
Products Product BIOTECH
  Product 2 Biolaminin® substrate
Persons Person Gäreskog, Mattias (BioLamina 202309– promoted to Chief Commercial Officer fomerly at Mercodia AB)
  Person 2 Sköld, Veronica Byfield (BioLamina 202308 CEO)
     


BioLamina is pleased to announce the appointment of Dr. Mattias Gäreskog as the new Chief Commercial Officer (CCO) and of Lotta Larsson as the new Head of People.

Dr. Gäreskog brings a wealth of experience from the commercial field, with more than 15 years in commercial roles at Mercodia AB, including most recently as Managing Director Marketing & Sales. Having previously served as Business Development Manager within BioLamina, he possesses a comprehensive understanding of the company’s operations, market dynamics and customers. He also holds a PhD from Uppsala University, Sweden, where he explored the biological pathways leading to diabetic complications and possible treatments of adverse effects.

Lotta Larsson has a solid 15-year experience of establishing and running a global HR function in a fast-growing, international and life science environment. Before joining BioLamina, she was the Global HR Manager of the medtech company RaySearch Laboratories AB, where she successfully accompanied their upscaling journey. She holds two Bachelors of Applied Science, in Health Sciences Health Promotion and Dietetics and Clinical Nutrition, from the University of Melbourne, Australia.

“We are thrilled to welcome Mattias and Lotta in the management team. As we continue to pursue our vision of becoming the leading provider of primary cell culture solutions to enable life-saving therapies, I feel confident that the breadth of their experience and expertise, their leadership qualities and values will allow them to develop both their teams as well as the overall company.”
Veronica Byfield Sköld, CEO of BioLamina

“It is an honor to lead the commercial unit of such a fantastic company as BioLamina. I am looking forward to driving our commercial efforts going forward and to helping the team reach new heights. Contributing to improving global health has always been important to me and what could be better than being part of BioLamina’s journey within the rapidly evolving cell therapy market!”
Dr. Mattias Gäreskog, the new CCO

“I am excited to join BioLamina as the new Head of People during this critical phase of upscaling. Our employees are the driving force behind BioLamina’-s achievements and I am dedicated to ensuring that we continue to nurture our talent, keep fostering inclusiveness, and retain our values, so that our people continue to be at the forefront of our growth story.”
Lotta Larsson, the new Head of People


For more information, please contact:

Veronica Byfield Sköld, CEO
Phone: +46 73 073 39 33
E-mail: communications@biolamina.com

   
Record changed: 2024-01-20

Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for BioLamina (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x300px




» top